Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Palanikumar Ravindran"'
Autor:
Rosa Ayala, Nieves Lopez, Adi Shacham Abulafia, Maan Alwan, Costas K. Yannakou, Indu Raman, Vincent Ribrag, Chun Yew Fong, Yulia Volchek, Massimiliano Bonifacio, Alessandra Tucci, Jean-Jacques Kiladjian, Jésus Marïa Hernandez Rivas, Blanca Xicoy, Haifa Kathrin Al-Ali, Jean-Christope Ianotto, Si Tuen Lee-Hoeflich, Sharmilla Das, Bin Wu, Palanikumar Ravindran, Qian Zhao, Guan Wang, Oriana Esposito, Yu Liu, Zariana Nikolova, Christopher Tehlirian, Shodeinde Coker, David Lavie
Publikováno v:
HemaSphere, Vol 7, p e4785165 (2023)
Externí odkaz:
https://doaj.org/article/5471365b11ed4d9dae2a907cb4fdd2ca
Autor:
Vivek Khemka, Claire Friedman, Georgia Kollia, Paolo Ascierto, Mark O’Hara, Lee James, Bruce Fischer, Shilpa Demes, Martin Kozicki, Palanikumar Ravindran, Jacqueline Shoukry, Mona Yunan, Ashish Massey
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/318c5366941a481ca9214cff381a23b2
Autor:
Rosa Ayala, Nieves Lopez, Adi Shacham Abulafia, Maan Alwan, Costas K. Yannakou, Indu Raman, Vincent Ribrag, Chun Yew Fong, Yulia Volchek, Massimiliano Bonifacio, Alessandra Tucci, Jean-Jacques Kiladjian, Henry Chang, Sharmila Das, Bin Wu, Palanikumar Ravindran, Vivian Shan, Guan Wang, Oriana Esposito, Yu Liu, Zariana Nikolova, Christopher Tehlirian, Shodeinde Coker, David Lavie
Publikováno v:
Blood. 140:9665-9667
Autor:
Claire Friedman, Richard Carvajal, Diwakar Davar, Eduardo Castanon, Paolo Ascierto, Emiliano Calvo, Mark O'Hara, Steven Powell, Ronnie Shapira-Frommer, Elena Garralda, Daniel John Renouf, Ruth Perets, Mona Yunan, Palanikumar Ravindran, Amy Hammell, Shaun O’Brien, Ke Xu, Nicholas Wilson, Amy Jhatakia, Anandaroop Mukhopadhyay, Martin Gutierrez
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Simon P Fletcher, Daniel J Chin, Lore Gruenbaum, Hans Bitter, Erik Rasmussen, Palanikumar Ravindran, David C Swinney, Fabian Birzele, Roland Schmucki, Stefan H Lorenz, Erhard Kopetzki, Jade Carter, Miriam Triyatni, Linta M Thampi, Junming Yang, Dalal AlDeghaither, Marta G Murreddu, Paul Cote, Stephan Menne
Publikováno v:
PLoS Pathogens, Vol 12, Iss 3, p e1005541 (2016)
Externí odkaz:
https://doaj.org/article/13b820dddb7745f69a4fca4a08965459
Autor:
Simon P Fletcher, Daniel J Chin, Lore Gruenbaum, Hans Bitter, Erik Rasmussen, Palanikumar Ravindran, David C Swinney, Fabian Birzele, Roland Schmucki, Stefan H Lorenz, Erhard Kopetzki, Jade Carter, Miriam Triyatni, Linta M Thampi, Junming Yang, Dalal AlDeghaither, Marta G Murreddu, Paul Cote, Stephan Menne
Publikováno v:
PLoS Pathogens, Vol 11, Iss 9, p e1005103 (2015)
Recombinant interferon-alpha (IFN-α) is an approved therapy for chronic hepatitis B (CHB), but the molecular basis of treatment response remains to be determined. The woodchuck model of chronic hepatitis B virus (HBV) infection displays many charact
Externí odkaz:
https://doaj.org/article/490241e2b789474f94c1b6547a08b2f4
Autor:
John Hilton, Mihaela Cristea, Sophie Postel-Vinay, Capucine Baldini, Mark Voskoboynik, William Edenfield, Geoffrey I. Shapiro, Michael L. Cheng, Jacqueline Vuky, Bradley Corr, Sharmila Das, Abraham Apfel, Ke Xu, Martin Kozicki, Keziban Ünsal-Kaçmaz, Amy Hammell, Guan Wang, Palanikumar Ravindran, Georgia Kollia, Oriana Esposito, Shodeinde Coker, Jennifer R. Diamond
Publikováno v:
Cancers; Volume 14; Issue 17; Pages: 4079
This phase 1/2a, open-label study (NCT02419417) evaluated the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of BMS-986158, a selective bromodomain and extraterminal domain (BET) inhibitor. Dose escalation was performed with 3 BMS-
Autor:
Ruoqi Peng, Sriram Sridhar, Gaurav Tyagi, Jonathan E Phillips, Rosario Garrido, Paul Harris, Lisa Burns, Lorena Renteria, John Woods, Leena Chen, John Allard, Palanikumar Ravindran, Hans Bitter, Zhenmin Liang, Cory M Hogaboam, Chris Kitson, David C Budd, Jay S Fine, Carla M T Bauer, Christopher S Stevenson
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e59348 (2013)
The preclinical model of bleomycin-induced lung fibrosis, used to investigate mechanisms related to idiopathic pulmonary fibrosis (IPF), has incorrectly predicted efficacy for several candidate compounds suggesting that it may be of limited value. As
Externí odkaz:
https://doaj.org/article/f1de7e184b004255ba62f718b13adc00
Autor:
Paolo A. Ascierto, Martin Kozicki, Mona Yunan, Georgia Kollia, Ashish Massey, Palanikumar Ravindran, Bruce S. Fischer, Li Li, Martin Gutierrez, Shilpa Demes, Matthew Dallos, Vivek Khemka, Mark H. O'Hara, Diwakar Davar, Claire F. Friedman, Ke Xu, Jacqueline Shoukry, Lee P. James, Ronnie Shapira-Frommer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background CTLA-4 pathway blockade with ipilimumab (IPI) ± nivolumab (NIVO; anti–PD-1) is an effective treatment for several cancers. A nonfucosylated version of IPI, BMS-986218, was developed to increase the effects of CTLA-4 blockade and enhance
Autor:
Florence Allantaz, Donavan T Cheng, Tobias Bergauer, Palanikumar Ravindran, Michel F Rossier, Martin Ebeling, Laura Badi, Bernhard Reis, Hans Bitter, Matilde D'Asaro, Alberto Chiappe, Sriram Sridhar, Gonzalo Duran Pacheco, Michael E Burczynski, Denis Hochstrasser, Jacky Vonderscher, Thomas Matthes
Publikováno v:
PLoS ONE, Vol 7, Iss 1, p e29979 (2012)
Blood consists of different cell populations with distinct functions and correspondingly, distinct gene expression profiles. In this study, global miRNA expression profiling was performed across a panel of nine human immune cell subsets (neutrophils,
Externí odkaz:
https://doaj.org/article/a09b488f612142eb9150e0324b41df65